Cargando…
Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease
OBJECTIVES: Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160459/ https://www.ncbi.nlm.nih.gov/pubmed/37152940 http://dx.doi.org/10.3389/fendo.2023.1163682 |
_version_ | 1785037283238346752 |
---|---|
author | Wang, Hongyan Zhang, Yuxue Liu, Yupeng Li, Hui Xu, Ruiling Fu, Hongmei Yan, Chaoqi Qu, Bo |
author_facet | Wang, Hongyan Zhang, Yuxue Liu, Yupeng Li, Hui Xu, Ruiling Fu, Hongmei Yan, Chaoqi Qu, Bo |
author_sort | Wang, Hongyan |
collection | PubMed |
description | OBJECTIVES: Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and assess their screening ability. METHODS: 12,658 subjects aged 18-75 at the Health Center of a Class III Grade A Hospital were included, who were divided into MAFLD and non-MAFLD groups. Spearman’s rank correlation was used to study the correlation between MAFLD and obesity measurement indexes. Receiver operating characteristic (ROC) curves were used to calculate the area under the curve (AUC) to evaluate their screening accuracy. RESULTS: MAFLD had strong correlation with traditional BMI and new index LAP. ROC analysis showed that BMI had the highest AUC (0.89), followed by LAP (0.87). Stratification by BMI, LAP had the highest AUC (0.90) for MAFLD in population without obesity (BMI< 23kg/m(2)), and its optimal cutoff value was 20.75, with a sensitivity and specificity of 85.9% and 79.0%, respectively. CONCLUSIONS: We proposed a two-step screening strategy for MAFLD, combining BMI and LAP, and defined a high-risk population for MAFLD as follows: 1) BMI ≥ 23 kg/m(2); and 2) BMI< 23 kg/m(2) and LAP ≥ 20.75. |
format | Online Article Text |
id | pubmed-10160459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101604592023-05-06 Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease Wang, Hongyan Zhang, Yuxue Liu, Yupeng Li, Hui Xu, Ruiling Fu, Hongmei Yan, Chaoqi Qu, Bo Front Endocrinol (Lausanne) Endocrinology OBJECTIVES: Obesity measurement indexes have certain screening value for metabolic diseases. To investigate associations between metabolic associated fatty liver disease (MAFLD) and obesity measurement indexes, including traditional indexes (BMI, WC, WHtR) and new indexes (ABSI, BRI, VAI, LAP), and assess their screening ability. METHODS: 12,658 subjects aged 18-75 at the Health Center of a Class III Grade A Hospital were included, who were divided into MAFLD and non-MAFLD groups. Spearman’s rank correlation was used to study the correlation between MAFLD and obesity measurement indexes. Receiver operating characteristic (ROC) curves were used to calculate the area under the curve (AUC) to evaluate their screening accuracy. RESULTS: MAFLD had strong correlation with traditional BMI and new index LAP. ROC analysis showed that BMI had the highest AUC (0.89), followed by LAP (0.87). Stratification by BMI, LAP had the highest AUC (0.90) for MAFLD in population without obesity (BMI< 23kg/m(2)), and its optimal cutoff value was 20.75, with a sensitivity and specificity of 85.9% and 79.0%, respectively. CONCLUSIONS: We proposed a two-step screening strategy for MAFLD, combining BMI and LAP, and defined a high-risk population for MAFLD as follows: 1) BMI ≥ 23 kg/m(2); and 2) BMI< 23 kg/m(2) and LAP ≥ 20.75. Frontiers Media S.A. 2023-04-21 /pmc/articles/PMC10160459/ /pubmed/37152940 http://dx.doi.org/10.3389/fendo.2023.1163682 Text en Copyright © 2023 Wang, Zhang, Liu, Li, Xu, Fu, Yan and Qu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Wang, Hongyan Zhang, Yuxue Liu, Yupeng Li, Hui Xu, Ruiling Fu, Hongmei Yan, Chaoqi Qu, Bo Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease |
title | Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease |
title_full | Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease |
title_fullStr | Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease |
title_full_unstemmed | Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease |
title_short | Comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease |
title_sort | comparison between traditional and new obesity measurement index for screening metabolic associated fatty liver disease |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160459/ https://www.ncbi.nlm.nih.gov/pubmed/37152940 http://dx.doi.org/10.3389/fendo.2023.1163682 |
work_keys_str_mv | AT wanghongyan comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease AT zhangyuxue comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease AT liuyupeng comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease AT lihui comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease AT xuruiling comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease AT fuhongmei comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease AT yanchaoqi comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease AT qubo comparisonbetweentraditionalandnewobesitymeasurementindexforscreeningmetabolicassociatedfattyliverdisease |